Nicholas Zolnerowich

Nicholas Zolnerowich

Auto-generated profile, based on publicly available information

Nicholas Zolnerowich

Laboratory of Genome Integrity, National Cancer Institute NIH, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2022 in Science
Verified
Journal Article
Closed access
DWDongpeng Wang
Dongpeng Wang
WWWei Wu
Wei Wu
ECElsa Callen
Elsa Callen
RPRaphael Pavani
Raphael Pavani
NZNicholas Zolnerowich
Nicholas Zolnerowich
ANAndré Nussenzweig
André Nussenzweig
Neurons harbor high levels of single-strand DNA breaks (SSBs) that are targeted to neuronal enhancers, but the source of this endogenous damage remains unclear. Using two systems of postmitotic lineage specification—induced pluripotent stem cell–derived neurons and transdifferentiated macrophages—we show that thymidine DNA glycosylase (TDG)–driven excision of methylcytosines oxidized with ten-eleven translocation enzymes (TET) is a source of SSBs. Although macrophage differentiation favors short-patch base excision repair to fill in single-nucleotide gaps, neurons also frequently use the long-patch subpathway. Disrupting this gap-filling process using anti-neoplastic cytosine analogs triggers a DNA damage response and neuronal cell death, which is dependent on TDG. Thus, TET-mediated active DNA demethylation promotes endogenous DNA damage, a process that normally safeguards cell identity but can also provoke neurotoxicity after anticancer treatments.